Phosphatidylcholine Use in Atherosclerosis & Range of Other Reports

At the Physician Education Awareness Training held on 15th October 2019 in Kota Kinabalu, Malaysia, Prof. Dr. Yuriy Nalapko conducted a session on Phosphatidylcholine Use in Atherosclerosis and Beyond.

His presentation explored the role of phosphatidylcholine in promoting cardiovascular health, particularly its effectiveness in addressing atherosclerosis by reducing plaque buildup and improving lipid metabolism. Dr. Yuriy also discussed a range of other clinical applications, including liver support, cellular membrane repair, and neuroprotection.

Attendees gained valuable insights into the science behind phosphatidylcholine therapy, its benefits, and practical guidelines for integrating it into treatment protocols. This session provided healthcare professionals with a deeper understanding of how this essential phospholipid contributes to overall health and disease prevention.